Background&Objective: Decrease in production of erythropoietin has been noted as one of the main factors causing anemia in ESRD patients, and administration of recombinant human erythropoietin (rhEPO) has been used to correct the anemia. Iron deficiency, including functional iron deficiency, limits the efficacy of rhEPO therapy in ESRD patients. This study examined the effects of maintenance intravenous iron sucrose (Venofer) on haemoglobin level and, optimization of erythropoietin therapy. Materials&Methods: Forty eight haemodialysis patients with haemoglobin level<9 gr/dl who were dialyzed three times weekly went under the study. Two thousands units of rhEPO were given subcutaneously at the end of each dialysis for seven weeks. At the end...
Anemia in patients suffering from end-stage renal failure is currently treated with Erythropoiesis-S...
Trials raising concerns about erythropoiesis-stimulating agents, revisions to their labeling, and ch...
Introduction Intravenous iron in combination with erythropoietin therapy is essential in maintainin...
Introduction: Anemia is the most common finding in chronic kidney disease patients. Iron supplements...
In patients with chronic kidney disease, treatment with erythropoiesis-stimulating agents (ESA) effe...
Aim: To compare the effects of i.v. iron sucrose and Fe chloride on the iron indices of haemodialysi...
Background: We determined optimal serum ferritin for oral iron therapy (OIT) in hemodialysis (HD) pa...
A randomized controlled study of iron supplementation in patients treated with erythropoietin. In vi...
Erythropoietin hyporesponsiveness: From iron deficiency to iron overload. Iron deficiency is the mos...
Patients with chronic kidney disease (CKD), especially those requiring maintenance hemodialysis trea...
Much progress has been made in recent years in the management of anemia associated with chronic and ...
The human recombinant erythropoietin (hrEpo) is crucial in anemia treatment options in chronic renal...
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human...
Beneficial effects of iron therapy in renal failure patients on hemodialysis. Iron deficiency is a c...
Introduction: Hemodialysis patients often develop resistance to recombinant human erythropoietin due...
Anemia in patients suffering from end-stage renal failure is currently treated with Erythropoiesis-S...
Trials raising concerns about erythropoiesis-stimulating agents, revisions to their labeling, and ch...
Introduction Intravenous iron in combination with erythropoietin therapy is essential in maintainin...
Introduction: Anemia is the most common finding in chronic kidney disease patients. Iron supplements...
In patients with chronic kidney disease, treatment with erythropoiesis-stimulating agents (ESA) effe...
Aim: To compare the effects of i.v. iron sucrose and Fe chloride on the iron indices of haemodialysi...
Background: We determined optimal serum ferritin for oral iron therapy (OIT) in hemodialysis (HD) pa...
A randomized controlled study of iron supplementation in patients treated with erythropoietin. In vi...
Erythropoietin hyporesponsiveness: From iron deficiency to iron overload. Iron deficiency is the mos...
Patients with chronic kidney disease (CKD), especially those requiring maintenance hemodialysis trea...
Much progress has been made in recent years in the management of anemia associated with chronic and ...
The human recombinant erythropoietin (hrEpo) is crucial in anemia treatment options in chronic renal...
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human...
Beneficial effects of iron therapy in renal failure patients on hemodialysis. Iron deficiency is a c...
Introduction: Hemodialysis patients often develop resistance to recombinant human erythropoietin due...
Anemia in patients suffering from end-stage renal failure is currently treated with Erythropoiesis-S...
Trials raising concerns about erythropoiesis-stimulating agents, revisions to their labeling, and ch...
Introduction Intravenous iron in combination with erythropoietin therapy is essential in maintainin...